RGS 0.00% 12.0¢ regeneus ltd

News: Regeneus hits key stem cell manufacturing milestone, page-7

  1. 4,624 Posts.
    lightbulb Created with Sketch. 141
    Dr Glenn Richards coming on board and purchasing a sizeable amount of shares coupled with the low market cap makes rgs look very nice imo. Just the veterinary side of regeneus market potential would make this many multiples of current market cap and Dr Richards the man to open these doors imo  


    Dr Glenn Richards was one of the founders of (ASX:GXL) which is now over a billion dollar company!

    Glen is the founding Managing Director of Greencross and was a co founder and Director of Mammoth Pet Holdings Pty Ltd prior to the merger with Greencross. He practiced companion animal medicine and surgery in Brisbane, Townsville and London before commencing practice ownership and establishing Greencross Vets in Townsville in 1994. Glen is a past Director of Lyppard Australia, one of Australia’s leading Veterinary wholesalers. He established China’s first western veterinary practice (Shanghai PAW) in 2001. He has been a Member of Australian Veterinary Association since 1988, with special interest groups in small animals and practice management
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.